SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-22-009223
Filing Date
2022-04-14
Accepted
2022-04-14 17:10:35
Documents
12
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A aveo-pre14ax2022xwithproxy.htm PRE 14A 1120781
2 GRAPHIC aveo-pcx4x13x22mbxip001.jpg GRAPHIC 158383
3 GRAPHIC aveo-pcx4x13x22mbxip002.jpg GRAPHIC 126698
4 GRAPHIC aveologo.jpg GRAPHIC 9024
5 GRAPHIC calculator.jpg GRAPHIC 1867
6 GRAPHIC envelopesymbol.jpg GRAPHIC 8258
7 GRAPHIC governmentbuildingimage.jpg GRAPHIC 8222
8 GRAPHIC image.jpg GRAPHIC 849
9 GRAPHIC laptopsymbol.jpg GRAPHIC 6559
10 GRAPHIC michaelbaileysignature.jpg GRAPHIC 2922
11 GRAPHIC piechartsymbol.jpg GRAPHIC 1817
12 GRAPHIC textmobilesymbol.jpg GRAPHIC 7528
  Complete submission text file 0001628280-22-009223.txt   1574786
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34655 | Film No.: 22828168
SIC: 2834 Pharmaceutical Preparations